BBK Worldwide to expand in E.U. and Latin America

Wednesday, April 13, 2011 12:15 PM

BBK Worldwide will expand in Europe and Latin America under the direction of Tatiana Sultzbach, who recently joined the patient recruitment firm in its market development department. 

“Although clinical research continues its movement toward a multinational enterprise, there is no substitute for local presence in each country in which a study will be conducted,” Sultzbach said. “We will continue to build upon the network to ensure that patient perspectives and needs are fully integrated into all aspects of study planning.” 

Sultzbach expects to announce six new BBK alliance partners within the next several months. A native of Bogotá, Colombia, Sultzbach previously served as director of international services for the Methodist Healthcare System in San Antonio, Texas. There, she launched the International Physician Panel which recruited physicians around the world to expand their training at Methodist Healthcare facilities -- with the goal of transferring medical knowledge and techniques back to their countries of origin.

“Partnering is a critical component of our industry,” said BBK co-founder Bonnie A. Brescia, “and Tatiana’s strengths in building collaborations throughout the health-care community will bring even more value to study sponsors and their research partners.”

 

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs